GlassScriptPhysician profile
Randall Richwine
NPI 1710910740
$30,145.44
in general payments reported to CMS, 2019-2025
65 companies · $1,856 in 2025
The $1,856 reported for 2025 was more than what 95% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,862 · 2020: $7,512 · 2021: $3,849 · 2022: $4,478 · 2023: $1,872 · 2024: $3,717 · 2025: $1,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,683 · Consulting Fee: $1,652 · Education: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,682.87 |
| Consulting Fee | $1,652.00 |
| Education | $109.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $12,771.48 | 2019-2025 | |
| Pfizer International LLC | $2,800.00 | 2020-2021 | |
| Novo Nordisk INC | $2,563.40 | 2019-2025 | Wegovy, Rybelsus, Ozempic |
| Sanofi-Aventis U.S. LLC | $2,441.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,057.29 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $856.13 | 2019-2025 | Jardiance |
| Abbvie INC. | $755.01 | 2021-2025 | |
| Lilly USA, LLC | $737.75 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $624.54 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Corium, LLC | $479.14 | 2022-2024 | Azstarys |
| Astellas Pharma US INC | $400.64 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $398.08 | 2021-2025 | |
| Tris Pharma INC | $355.28 | 2022-2025 | Dyanavel Xr, Quillivant, Quillichew Er |
| Amgen INC. | $261.43 | 2019-2024 | Otezla, Repatha |
| Allergan, INC. | $216.90 | 2019-2020 |
Show all 63 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $211.94 | 2020-2022 | |
| Dexcom, INC. | $200.77 | 2022-2025 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $196.87 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Merck Sharp & Dohme LLC | $195.08 | 2019-2023 | Belsomra, Steglujan, Steglatro |
| Biohaven Pharmaceutical Holding Company LTD. | $191.62 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $188.59 | 2020-2022 | |
| Amarin Pharma, INC. | $181.27 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $168.64 | 2019-2025 | |
| Inspire Medical Systems, INC. | $152.43 | 2024-2025 | Inspire |
| Nalu Medical, INC. | $145.01 | 2024 | Nalu Neurostimulation System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $130.87 | 2020-2023 | Xifaxan, Trulance |
| Biohaven Pharmaceuticals, INC. | $127.21 | 2020-2021 | |
| Abbott Laboratories | $105.20 | 2022-2025 | Freestyle Libre, Proclaim, Afinion 2 |
| Otsuka America Pharmaceutical, INC. | $99.87 | 2022-2025 | Rexulti |
| Exact Sciences Corporation | $91.98 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $87.67 | 2019-2021 | |
| Corcept Therapeutics | $76.47 | 2025 | Korlym |
| Supernus Pharmaceuticals, INC. | $65.36 | 2021-2023 | Xyosted, Qelbree |
| Ironshore Pharmaceuticals INC. | $61.30 | 2019-2024 | |
| Phathom Pharmaceuticals, INC. | $61.23 | 2024-2025 | Voquezna |
| Genentech USA, INC. | $60.47 | 2019-2021 | |
| Shire North American Group INC | $58.42 | 2019 | |
| Halozyme INC | $56.54 | 2023 | |
| Lundbeck LLC | $34.27 | 2025 | Vyepti, Rexulti |
| Dynavax Technologies Corporation | $33.95 | 2024 | Heplisav-B |
| Axsome Therapeutics, INC. | $33.90 | 2024-2025 | Auvelity |
| Sanofi Pasteur INC. | $33.87 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $31.30 | 2022-2025 | Gvoke Hypopen |
| Tolmar, INC. | $27.98 | 2023-2025 | Jatenzo |
| Ultragenyx Pharmaceutical INC. | $26.49 | 2021-2023 | Crysvita |
| Olympus America INC. | $25.57 | 2023 | Spiration Valve System |
| Tactile Systems Technology INC | $22.96 | 2023 | Entre Plus, Flexitouch Plus |
| Adlon Therapeutics L.P. | $19.29 | 2020 | |
| Globus Medical, INC. | $18.06 | 2025 | Senza |
| Pacira Therapeutics, INC. | $17.75 | 2019 | |
| Ibsa Pharma INC. | $17.09 | 2023 | Tirosint, Licart |
| Kaleo, INC. | $16.63 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.44 | 2019 | |
| Seqirus USA INC | $15.98 | 2021 | |
| Si-Bone, INC. | $15.51 | 2019 | |
| Medtronic, INC. | $15.42 | 2025 | Inceptiv |
| Idorsia Pharmaceuticals US INC | $15.26 | 2023 | Quviviq |
| Ethicon US, LLC | $13.86 | 2019 | |
| Depuy Synthes Sales INC. | $13.67 | 2023 | Monovisc |
| Collegium Pharmaceutical, INC. | $13.65 | 2025 | Jornay Pm |
| Nabriva Therapeutics, Plc | $11.62 | 2020 | |
| Endo Pharmaceuticals INC. | $11.60 | 2020 | |
| Clarus Therapeutics INC. | $10.02 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randall Richwine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.